Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Transcode Therapeutics, Inc. (RNAZ) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Transcode Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1829635.
Total stock buying since 2022: $269,870.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 184,957 | $176,258 | 0 | $0 | 0 | $0 |
| 2022 | 62,000 | $93,612 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 147,350 | $75,148 | 0 | $0 | 0 | $0 |
| 2023-06 | 37,607 | $101,110 | 0 | $0 | 0 | $0 |
| 2022-09 | 20,000 | $23,000 | 0 | $0 | 0 | $0 |
| 2022-06 | 12,000 | $15,240 | 0 | $0 | 0 | $0 |
| 2022-05 | 30,000 | $55,372 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-28 | Fitzgerald Thomas A (Chief Financial Officer) | Buy | 49,350 | .51 | 25,168 |
| 2023-09-28 | Dudley Robert Michael (Chief Executive Officer) | Buy | 98,000 | .51 | 49,980 |
| 2023-06-21 | Dudley Robert Michael (Chief Executive Officer) | Buy | 12,000 | 2.65 | 31,824 |
| 2023-06-20 | Dudley Robert Michael (Chief Executive Officer) | Buy | 6,607 | 2.55 | 16,847 |
| 2023-06-09 | Dudley Robert Michael (Chief Executive Officer) | Buy | 19,000 | 2.76 | 52,439 |
| 2022-09-14 | Dudley Robert Michael (Chief Executive Officer) | Buy | 20,000 | 1.15 | 23,000 |
| 2022-06-16 | Fitzgerald Thomas A (Chief Financial Officer) | Buy | 12,000 | 1.27 | 15,240 |
| 2022-05-31 | Dudley Robert Michael (Chief Executive Officer) | Buy | 2,000 | 1.87 | 3,740 |
| 2022-05-27 | Dudley Robert Michael (Chief Executive Officer) | Buy | 28,000 | 1.84 | 51,632 |
Insider trading activities including stock purchases, stock sales, and option exercises of RNAZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Transcode Therapeutics, Inc. (symbol RNAZ, CIK number 1829635) see the Securities and Exchange Commission (SEC) website.